CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2/3, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Baricitinib in Adult and Pediatric Japanese Patients With NNS/CANDLE, SAVI, and AGS

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04517253
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:36.720968+00:00
Published At: 2022-12-21T00:00:00+00:00
Record Updated At: 2025-07-10
Results Posted At: 2022-12-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Nakajo-Nishimura Syndrome", "Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome", "STING-Associated Vasculopathy With Onset in Infancy", "Aicardi Goutieres Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-10"
protocolSection.identificationModule.nctId: "NCT04517253"
protocolSection.identificationModule.officialTitle: "A Phase 2/3, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Baricitinib in Adult and Pediatric Japanese Patients With NNS/CANDLE, SAVI, and AGS"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-12-21"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.